ASSAY RECORD
Results
Showing up to 20 records.
| NO. | RECORD ID | NAME | SEQUENCE | SOURCE ORGANISM | FUNCTION CATEGORY | TARGET ORGANISM | ACTIVITY | ASSAY METHOD | PMID | PATENT NO | VERIFICATION STATUS |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 419101 | Rec_0431759 | Thyrotropin-releasing hormone (TRH) |
EHP |
Rattus norvegicus [Animal] |
Hormone, Neuropeptide, Receptor binding |
rat brain TRH receptors |
6 nM | Kd (radioligand receptor binding assay) |
6087185 | - |
YES |
| 419102 | Rec_0431760 | P9 (Pro9 homopeptide) |
PPPPPPPPP |
synthetic construct [Synthetic] |
Antifreeze, Ice-binding, Thermal hysteresis |
ice/water crystallization system |
- | thermal hysteresis assay by differential scanning calorimetry (DSC) |
- | - |
YES |
| 419103 | Rec_0431761 | GAD65 peptide 524-538 (p524) |
SRLSKVAPVIKARMM |
synthetic construct [Synthetic] |
T-cell epitope, Immunomodulatory |
NOD mouse GAD65-reactive T cells / splenocytes |
- | T-cell proliferation and cytokine functional assay |
15322170 | - |
YES |
| 419104 | Rec_0431762 | Ergtoxin-1 (CnErg1/ErgTx) |
DRDSCVDKSRCAKYGYYQECQDCCKNAGHNGGTCMFFKCKCA |
Centruroides noxius [Animal] |
Toxin, Potassium channel blocker, hERG inhibitor |
human hERG (KCNH2/Kv11.1) potassium channel |
11.4 nM | Kd (electrophysiological channel-block dose-response) |
11755529 | - |
YES |
| 419105 | Rec_0431763 | TACE-binding peptide TRWLVYFSRPYLVAT |
TRWLVYFSRPYLVAT |
synthetic construct [Synthetic] |
Anti-inflammatory, TACE inhibitor |
TNF-alpha converting enzyme (TACE); LPS-stimulated human PBMCs |
60.3 % | TNF-alpha release inhibition |
16463648 | - |
YES |
| 419106 | Rec_0431764 | pBD-2 I4R analog |
DHYRCAKKGGTCNFSPCPLFNRIEGTCYSGKAKCCIR |
synthetic construct [Synthetic] |
Antimicrobial, Antibacterial |
Staphylococcus aureus ATCC 25923 |
- | turbidimetric growth inhibition assay (0–80 μg/mL) |
25719446 | - |
YES |
| 419107 | Rec_0431765 | pBD-2 I4R analog |
DHYRCAKKGGTCNFSPCPLFNRIEGTCYSGKAKCCIR |
synthetic construct [Synthetic] |
Hemolysis tested, Low hemolytic activity |
porcine erythrocytes |
<10 % | Hemolysis (0–80 μg/mL peptide) |
25719446 | - |
YES |
| 419108 | Rec_0431766 | Sequence 38 from antimicrobial peptide patent |
GLLGKIRKEGRMFWRVFRRWL |
synthetic construct [Synthetic] |
Antimicrobial, Antibacterial |
Escherichia coli TOP10 |
92 % | 14 h OD450 growth inhibition assay (0.1% arabinose induction) |
- | US 2007/0259087 A1 |
YES |
| 419109 | Rec_0431767 | [N9G] Vc1.1 |
GCCSDPRCGYDHPEIC |
synthetic construct [Synthetic] |
Nicotinic acetylcholine receptor antagonist |
human α9/rat α10 hybrid nicotinic acetylcholine receptor |
28 (4-214) nM | IC50 |
19447885 | - |
YES |
| 419110 | Rec_0431768 | [N9G] Vc1.1 |
GCCSDPRCGYDHPEIC |
synthetic construct [Synthetic] |
Nicotinic acetylcholine receptor antagonist |
rat α3β2 nicotinic acetylcholine receptor |
≥3000 nM | IC50 |
19447885 | - |
YES |
| 419111 | Rec_0431769 | [N9G] Vc1.1 |
GCCSDPRCGYDHPEIC |
synthetic construct [Synthetic] |
Nicotinic acetylcholine receptor antagonist |
rat α3β4 nicotinic acetylcholine receptor |
≥3000 nM | IC50 |
19447885 | - |
YES |
| 419112 | Rec_0431770 | [N9G] Vc1.1 |
GCCSDPRCGYDHPEIC |
synthetic construct [Synthetic] |
Nicotinic acetylcholine receptor antagonist |
rat α7 nicotinic acetylcholine receptor |
≥3000 nM | IC50 |
19447885 | - |
YES |
| 419113 | Rec_0431771 | Tyrosinase 309-318 T-cell epitope |
TPRLPSSADV |
Homo sapiens [Animal] |
T-cell epitope, Immunogenic, Anticancer |
HLA-B7; peripheral-blood CD8+ T cells from melanoma patients |
1/18 positive responses / HLA-B7 melanoma patients | MHC multimer-based enrichment T-cell response assay |
25854582 | - |
YES |
| 419114 | Rec_0431772 | Clone 25 |
FYCVIERLGVCLY |
synthetic construct [Synthetic] |
Tumor-targeting, Breast cancer cell targeting, Cell-binding |
ZR-75-1 human breast carcinoma cells |
- | fluorescent bacterial display / fluorescence-activated cell sorting (FACS) binding assay |
16448666 | - |
YES |
| 419115 | Rec_0431773 | Schistomyotropin-2 (Scg-MT-2) |
TSSLFPHPRL |
Schistocerca gregaria [Animal] |
Myotropic, Hindgut motility stimulant, Neuropeptide |
cockroach hindgut |
- | hindgut motility assay |
- | - |
YES |
| 419116 | Rec_0431774 | Rhopr-FGLa/AST-3 |
AHNEGRLYSFGL |
Rhodnius prolixus [Animal] |
Receptor agonist, Allatostatin signaling, Neuropeptide |
Rhodnius prolixus FGLamide-related allatostatin receptor (Rhopr-FGLa/AST-R) |
- | heterologous receptor activation assay (intracellular calcium response) |
25500190 | - |
YES |
| 419117 | Rec_0431775 | LK(11) |
LKLKLKLKLKLKLKLKLKLKLK |
synthetic construct [Synthetic] |
Antimicrobial, Antibacterial |
Pseudomonas aeruginosa ATCC 10145 |
51 μg/mL | IC50 |
- | US 7091185 B2 |
YES |
| 419118 | Rec_0431776 | LK(11) |
LKLKLKLKLKLKLKLKLKLKLK |
synthetic construct [Synthetic] |
Antimicrobial, Antibacterial |
Pseudomonas aeruginosa ATCC 10145 |
62 μg/mL | MIC |
- | US 7091185 B2 |
YES |
| 419119 | Rec_0431777 | LK(11) |
LKLKLKLKLKLKLKLKLKLKLK |
synthetic construct [Synthetic] |
Antimicrobial, Antibacterial |
Escherichia coli ATCC 2592 |
50 μg/mL | IC50 |
- | US 7091185 B2 |
YES |
| 419120 | Rec_0431778 | LK(11) |
LKLKLKLKLKLKLKLKLKLKLK |
synthetic construct [Synthetic] |
Antimicrobial, Antibacterial |
Escherichia coli ATCC 2592 |
>125 μg/mL | MIC |
- | US 7091185 B2 |
YES |